|
|
| General
Patent Information on Inholtra |
U.S. Patent:
5,840,715
Date of Patent: Nov. 24, 1998
Abstract
This invention is directed to a dietary regimen and a unique
combination of nutritional supplements and a method. More
specifically, this invention is directed to a unique combination
of nutritional supplements which provides symptomatic relief
from arthritis. The unique combination of nutritional supplement
of this invention is believed to function by both increasing the
available (effective blood level) of anti-inflammatory agents
and promoting of the healing/regenerative process in the
effected joints, thus producing unexpected and lasting
symptomatic relief from the debilitating effects of both
osteo-arthritis and rheumatoid arthritis. The essential
nutritional supplements of hte dietary regimen of this invention
are as follows: (a) gamma linolenic acid (unrefined),
hereinafter "GLA"; (b) a mixture of eicosapentaenoic
acid an docosahexaneoic acid, hereinafter collectively
"EPA"; (c) a mixture of chondroitin sulfate, N-acetyl
glucosamine sulfate, glucosamine sulfate and maganese aspartate,
hereinafter collectively "CHONDROX". The regimen is
adjusted based upon the weight of the individual, and once
symptomatic relief is achieved, the individual remains
essentially free from the debilitating effects of arthritis so
as long the daily regimen is faithfully followed.
5 Claims, No Drawings
|
Nutritional
supplements, diet, weight loss, body building, vitamins, and
sports nutrition home page |